Tower Research Capital LLC (Trc) Medicenna Therapeutics Corp. Transaction History

Tower Research Capital LLC (Trc)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.79 - $1.32 $1,156 - $1,932	1,464 New	1,464 $2,000
Q1 2022 May 12, 2022	SELL	$1.26 - $1.92 $6,138 - $9,354	-4,872 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.53 - $2.85 $7,148 - $13,315	4,672 Added 2336.0%	4,872 $8,000
Q3 2021 Nov 15, 2021	SELL	$1.91 - $3.05 $1,827 - $2,918	-957 Reduced 82.71%	200 $1,000
Q2 2021 Aug 16, 2021	BUY	$2.97 - $4.28 $359 - $517	121 Added 11.68%	1,157 $3,000
Q1 2021 May 17, 2021	BUY	$3.5 - $4.56 $3,626 - $4,724	1,036 New	1,036 $4,000
Q4 2020 Feb 16, 2021	SELL	$3.7 - $5.97 $1,424 - $2,298	-385 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.55 - $4.67 $1,366 - $1,797	385 New	385 $2,000

863K

Ticker MDNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,637,504
Market Cap $21.6M
Description
Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.